- Home
- switzerland
- Companies
Refine by
Medical Industry Technology In Switzerland
27 companies found
Technologybased inSchlieren, SWITZERLAND
We want to empower people to deal with their malignant cells through their own immune system just like we deal with viral infections. Today’s cancer immunotherapies are powerful but, to the detriment of their effect, not very tumor-selective. ...
CDR-Life’s T cell engaging antibodies are potentially transformative in the field of cancer immunotherapies» Prof. Markus G. Manz, MD, Head of Medical Oncology and Hematology at University Hospital and University of Zurich, Switzerland. ...
Technologybased inDüdingen, SWITZERLAND
ORELL Tec AG (previously OLAER (Switzerland) AG) was founded in 1969 in Colombes (F) as a fiduciary of OLAER Industries SA. It was in 1976 that we were able to move to the facilities where we are currently locat-ed, in Düdingen (in the Canton of ...
OLAER bladder accumulators are ideal for any application. They can be recommended for use anywhere, where accumulators are used as energy reserve such as in hydrostatic bearings, lubricating oil supplies, chucking systems on machine tools, safety ...
Technologybased inGeneve, SWITZERLAND
ITS Water Group specializes in providing advanced chemical reagents and engineering services tailored for effective water and wastewater treatment solutions. The company focuses on delivering innovative technologies for municipal and industrial ...
Technologybased inWadenswil, SWITZERLAND
3Brain is the world’s first company to connect cells with sophisticated silicon chips in cell culture plates. Stemming from our passion for technology and scientific progress, our co-founders have worked for more than 15 years on CMOS-powered ...
The external IO Connector Box facilitates the access to the BioCAM X and BioCAM DupleX HD-MEA channels and internal modules (like the stimulation module). It features: 4 output stimulation channels, 1 input stimulation channel, 3 digital In/Out ...
Technologybased inEindhoven, NETHERLANDS
Xeltis is a clinical-stage medical device company pioneering a restorative approach in cardiovascular therapy. RestoreX™, Xeltis technology platform, is the world’s first polymer-based technology designed to enable natural restoration of ...
The aXess graft is a restorative, synthetic, electrospun blood vessel for arteriovenous hemodialyisis access, overtime turning into a living vessel made of patient’s own ...
Technologybased inLausanne, SWITZERLAND
Xsensio is an innovation-driven digital health company dedicated to solving one of the biggest challenges in healthcare: the lack of real-time, continuous monitoring of relevant health parameters. To achieve this vision, Xsensio is building the ...
Xsensio considerably expands the potential of wearable products with the development of a breakthrough wearable device that tracks – not physical data like today’s devices – but biochemical data in the interstitial fluid (ISF). At ...
Technologybased inNew York, NEW YORK (USA)
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to build ...
SL-801 is a structurally novel, oral, small molecule, reversible inhibitor of exportin-1 (XPO1), a nuclear transport protein implicated in both solid tumors and hematologic malignancies. SL-801 has demonstrated preclinical in vitro and in vivo ...
Technologybased inPréverenges, SWITZERLAND
Founded in 2016 by a group of experienced engineers and bio-informaticians under the leadership of Claudio Alberti, our CTO, GenomSys is a Swiss company developing state-of-the-art technology and services for the efficient analysis and secure ...
GenomSys Codec Suite is a collection of software tools to process genomic data compliant with ISO/IEC-23092 genomic data standard (MPEG-G). It is CE marked as an in-Vitro Diagnostic Medical Device according to 98/79/CE directive and hence approved ...
Technologybased inBasel, SWITZERLAND
Aurealis Therapeutics, a Swiss-Finnish private biopharmaceutical company, is now entering the clinical trial phase with its patented three-in-one combination product AUP-16 for chronic non-healing wounds and other regenerative diseases. The ...
Our new approach to chronic wound healing moves far beyond symptom ...
Technologybased inFlamatt, SWITZERLAND
As a trailblazing, leading tech company in radio frequency and x-ray technology, we make a growing contribution to a safer and more secure, more efficient and sustainable world of manufacturing, communication and mobility. For our customers in the ...
Technologybased inBubendorf, SWITZERLAND
CIS Pharma is an innovator in the life science industry in the field of Oncology and Ophthalmolog. We were awarded with the European Frost & Sullivan Technology Innovation Award for our unique smart polymer technologyœ, says Christoph Schäfer, CEO ...
Werner Schäfer, the founder of CIS Pharma, envisioned the synthesis of a bio-inspired polymer for tissue regeneration and site-specific drug delivery. We have generated a platform of proprietary polymers together with a toolkit to create ...
Technologybased inDubendorf, SWITZERLAND
VunaNexus uses a patented technology to transform human and livestock urine into two valuable products: a fertiliser free of all dangerous pollutants and water that can be reused, this while drastically reducing ammonia emissions and water ...
Aurin - The 1st urine fertiliser worldwide with full approval. Aurin is a universal fertiliser made from human urine. Vuna offers the process that converts urine into fertiliser. This removes drug residues, hormones and germs, but the ...
Technologybased inZürich, SWITZERLAND
Amcor is a world leader in innovative packaging. The company added a range of diverse packaging interests to its traditional papermaking activities. This was achieved through creating new business partnerships and making strategic acquisitions in ...
Technologybased inBethesda, MARYLAND (USA)
Gain Therapeutics is redefining drug discovery with its SEE-Txâ„¢ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for ...
Gain is utilizing its Site-Directed Enzyme Enhancement Therapy (See-Tx™) platform to guide misfolded enzymes back into their proper shape in order to treat a range of diseases. ...
Technologybased inLausanne, SWITZERLAND
Amazentis is an innovative life science company dedicated to employing breakthrough research and clinical science to bring advanced therapeutic nutrition products to life. We employ rigorous science to pioneer the discovery and clinical development ...
Mitopure® is a highly pure form of Urolithin A, a postbiotic clinically shown to energize cells, increase muscle strength and improve endurance. And this is just the beginning. New studies continuously explore and prove the incredible potential ...
Technologybased inWaiblingen, GERMANY
Syntegon stands as a strategic partner in the pharmaceutical and food processing and packaging sectors. Utilizing a heritage of 160 years, Syntegon's portfolio extends to standalone machines and comprehensive system solutions for primary and ...
Technologybased inMaur (Zurich), SWITZERLAND
We are delighted to introduce our current range of modular systems and individual components to you on the following pages. When Rolf Sieber first entered the market with SITEC in 1984, he could never have imagined the success the company enjoys ...
Technologybased inBasel, SWITZERLAND
T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of ...
Technologybased inSchlieren, SWITZERLAND
The biotech-company EraCal Therapeutics Ltd. is a spin-off from the University of Zurich and Harvard University. The company is privately held by a biotech-specialized investor base incl. BERNINA BioInvest, Redalpine, and UZH Life Sciences ...
EraCal’s platform enables unbiased and large-scale in vivo drug discovery in zebrafish larvae. The journal Science Advances published part of EraCal’s translational proof of concept. Such phenotypic strategies are capable of identifying ...
Technologybased inUrdorf, SWITZERLAND
Securecell AG specializes in pioneering advanced solutions within the biotech and MedTech industries. Their technological innovations focus on automated bioprocessing, high-throughput sampling, and the deployment of digital technologies to enhance ...
In its MedTech division, Securecell is proudly developing Seraccess®, an innovative technology that fully automates the high-frequency collection, processing, and analysis of blood using next generation microfluidics for the monitoring and ...